Skyran Biologics, Inc.
Harrisburg, PA
- UEI
- MMFAJMXZVCM3
- CAGE
- 7XLK6
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 2435 Kensington Way, Harrisburg, PA 17112, USA
- Website
- skyranbiologics.com
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Epigenetic modifiers to treat photoreceptor degenerations | National Eye Institute (NIH) | $143,791 | |
| A novel pedf peptide mimetic for diabetic retinopathy | National Eye Institute (NIH) | $1,622,109 | |
| A novel pedf peptide mimetic for diabetic retinopathy | National Eye Institute (NIH) | $204,756 |
Quick answers
Is Skyran Biologics, Inc. registered in SAM.gov?
Yes. Skyran Biologics, Inc.'s SAM.gov registration is active through September 29, 2027.
What is Skyran Biologics, Inc.'s most recent federal award?
Skyran Biologics, Inc.'s most recent federal grant award is Epigenetic modifiers to treat photoreceptor degenerations (R41EY035180), from National Eye Institute (NIH), on July 1, 2023.
On GovTribe
See Skyran Biologics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors